Skip to main content
Emergency Alert
Request an Appointment
Pay a Bill
Clinical Trials
Careers
MyChart
UVA Health Children's
UVA Health
Find a Provider
Services
Locations
Patients & Visitors
Search
Search
Menu
Find a Provider
Services
Locations
Patients & Visitors
Search
Appointments
Billing
Clinical Trials
MyChart
Home
Clinical Trial Categories
development
In This Section
Clinical Trials
Clinical Trials
Principal Investigator
Search for ‘
development
’ results: 1-8 of 8
Acute Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Hormone Studies
Hormone Study for Girls Ages 7 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Pancreatic Disorders
Type 2 Diabetes and Dexcom G6 Continuous Glucose Monitor Research Study
Polycystic Ovarian Syndrome
Hormone Study for Girls Ages 7 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone